Universe Pharmaceuticals INC
UPC
$5.94
-$1.15-16.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.05M | 29.05M | 33.59M | 33.59M | 47.27M |
| Total Receivables | 15.24M | 15.24M | 13.19M | 13.19M | 13.53M |
| Inventory | 3.98M | 3.98M | 4.68M | 4.68M | 3.57M |
| Prepaid Expenses | 588.70K | 588.70K | 883.70K | 883.70K | 39.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.35M | 6.35M | 1.26M | 1.26M | 621.80K |
| Total Current Assets | 55.21M | 55.21M | 53.60M | 53.60M | 65.03M |
|
|
|||||
| Total Current Assets | 55.21M | 55.21M | 53.60M | 53.60M | 65.03M |
| Net Property, Plant & Equipment | 3.79M | 3.79M | 3.58M | 3.58M | 3.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 309.80K | 309.80K | 296.80K | 296.80K | 266.80K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.43M | 11.43M | 11.12M | 11.12M | 11.40M |
| Total Assets | 71.47M | 71.47M | 69.30M | 69.30M | 80.67M |
|
|
|||||
| Total Accounts Payable | 3.75M | 3.75M | 1.67M | 1.67M | 7.40M |
| Total Accrued Expenses | 251.90K | 251.90K | 848.70K | 848.70K | 1.65M |
| Short-term Debt | 7.38M | 7.38M | 7.15M | 7.15M | 5.66M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 2.11M | 2.11M | -- |
| Total Finance Division Other Current Liabilities | 2.26M | 2.26M | 1.40M | 1.40M | 8.70M |
| Total Other Current Liabilities | 2.26M | 2.26M | 1.40M | 1.40M | 8.70M |
| Total Current Liabilities | 13.65M | 13.65M | 13.17M | 13.17M | 23.42M |
|
|
|||||
| Total Current Liabilities | 13.65M | 13.65M | 13.17M | 13.17M | 23.42M |
| Long-Term Debt | 2.17M | 2.17M | -- | -- | 2.07M |
| Short-term Debt | 7.38M | 7.38M | 7.15M | 7.15M | 5.66M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.82M | 15.82M | 13.17M | 13.17M | 25.48M |
|
|
|||||
| Common Stock & APIC | 69.35M | 69.35M | 69.35M | 69.35M | 69.35M |
| Retained Earnings | -12.96M | -12.96M | -11.40M | -11.40M | -11.02M |
| Treasury Stock & Other | -743.20K | -743.20K | -1.81M | -1.81M | -3.15M |
| Total Common Equity | 55.65M | 55.65M | 56.13M | 56.13M | 55.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 55.65M | 55.65M | 56.13M | 56.13M | 55.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.65M | 55.65M | 56.13M | 56.13M | 55.19M |
|
|
|||||